RIVAXOTOR 15 rivaroxaban 15 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rivaxotor 15 rivaroxaban 15 mg tablet blister pack

arrotex pharmaceuticals pty ltd - rivaroxaban, quantity: 15 mg/kg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; sodium lauryl sulfate; microcrystalline cellulose; hypromellose; croscarmellose sodium; titanium dioxide; iron oxide red; macrogol 3350 - ? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks),? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe

RIVAXOTOR  20 rivaroxaban 20 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rivaxotor 20 rivaroxaban 20 mg tablet blister pack

arrotex pharmaceuticals pty ltd - rivaroxaban, quantity: 20 mg/kg - tablet, film coated - excipient ingredients: hypromellose; microcrystalline cellulose; sodium lauryl sulfate; magnesium stearate; croscarmellose sodium; lactose monohydrate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - ? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks),? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe

Trivax-AD New Zealand - English - Medsafe (Medicines Safety Authority)

trivax-ad

glaxosmithkline nz limited - diphtheria toxoid, adsorbed 25 lf u; pertussis vaccine 4 [iu]; tetanus toxoid, adsorbed 5 lf u - solution for injection - 25lf/5lf/4iu - active: diphtheria toxoid, adsorbed 25 lf u pertussis vaccine 4 [iu] tetanus toxoid, adsorbed 5 lf u

Saphrivax-400 400 mg Tablet Philippines - English - FDA (Food And Drug Administration)

saphrivax-400 400 mg tablet

n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - acyclovir - tablet - 400 mg

TRIVAX D T P VACCINE Ireland - English - HPRA (Health Products Regulatory Authority)

trivax d t p vaccine

wellcome (ireland) limited - diphtheria toxoid tetanus toxoid pertussis toxoid -